Table of Contents

Global Biologics Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications

1 Study Coverage

• 1.1 Biologics Product
• 1.2 Key Market Segments in This Study
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Biologics Market Size Growth Rate by Type
  • 1.4.2 Monoclonal Antibodies
  • 1.4.3 Vaccines
  • 1.4.4 Recombinant Proteins
  • 1.4.5 Antisense
  • 1.4.6 RNAi
• 1.5 Market by Application
  • 1.5.1 Global Biologics Market Size Growth Rate by Application
  • 1.5.2 Infectious Diseases
  • 1.5.3 Oncology
  • 1.5.4 Immunology
  • 1.5.5 Autoimmune Diseases
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Biologics Production
  • 2.1.1 Global Biologics Revenue 2014-2025
  • 2.1.2 Global Biologics Production 2014-2025
  • 2.1.3 Global Biologics Capacity 2014-2025
  • 2.1.4 Global Biologics Marketing Pricing and Trends
• 2.2 Biologics Growth Rate (CAGR) 2019-2025
• 2.3 Analysis of Competitive Landscape
  • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 2.3.2 Key Biologics Manufacturers
• 2.4 Market Drivers, Trends and Issues
• 2.5 Macroscopic Indicator
  • 2.5.1 GDP for Major Regions
  • 2.5.2 Price of Raw Materials in Dollars: Evolution

3 Market Size by Manufacturers

• 3.1 Biologics Production by Manufacturers
  • 3.1.1 Biologics Production by Manufacturers
  • 3.1.2 Biologics Production Market Share by Manufacturers
• 3.2 Biologics Revenue by Manufacturers
  • 3.2.1 Biologics Revenue by Manufacturers (2014-2019)
  • 3.2.2 Biologics Revenue Share by Manufacturers (2014-2019)
• 3.3 Biologics Price by Manufacturers
• 3.4 Mergers & Acquisitions, Expansion Plans

4 Biologics Production by Regions

• 4.1 Global Biologics Production by Regions
  • 4.1.1 Global Biologics Production Market Share by Regions
  • 4.1.2 Global Biologics Revenue Market Share by Regions
• 4.2 United States
  • 4.2.1 United States Biologics Production
  • 4.2.2 United States Biologics Revenue
  • 4.2.3 Key Players in United States
  • 4.2.4 United States Biologics Import & Export
• 4.3 Europe
  • 4.3.1 Europe Biologics Production
  • 4.3.2 Europe Biologics Revenue
  • 4.3.3 Key Players in Europe
  • 4.3.4 Europe Biologics Import & Export
• 4.4 China
  • 4.4.1 China Biologics Production
  • 4.4.2 China Biologics Revenue
  • 4.4.3 Key Players in China
  • 4.4.4 China Biologics Import & Export
• 4.5 Japan
  • 4.5.1 Japan Biologics Production
  • 4.5.2 Japan Biologics Revenue
  • 4.5.3 Key Players in Japan
  • 4.5.4 Japan Biologics Import & Export
• 4.6 Other Regions
  • 4.6.1 South Korea
  • 4.6.2 India
  • 4.6.3 Southeast Asia

5 Biologics Consumption by Regions

• 5.1 Global Biologics Consumption by Regions
  • 5.1.1 Global Biologics Consumption by Regions
  • 5.1.2 Global Biologics Consumption Market Share by Regions
• 5.2 North America
  • 5.2.1 North America Biologics Consumption by Application
  • 5.2.2 North America Biologics Consumption by Countries
  • 5.2.3 United States
  • 5.2.4 Canada
  • 5.2.5 Mexico
• 5.3 Europe
  • 5.3.1 Europe Biologics Consumption by Application
  • 5.3.2 Europe Biologics Consumption by Countries
  • 5.3.3 Germany
  • 5.3.4 France
  • 5.3.5 UK
  • 5.3.6 Italy
  • 5.3.7 Russia
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Biologics Consumption by Application
  • 5.4.2 Asia Pacific Biologics Consumption by Countries
  • 5.4.3 China
  • 5.4.4 Japan
  • 5.4.5 South Korea
  • 5.4.6 India
  • 5.4.7 Australia
  • 5.4.8 Indonesia
  • 5.4.9 Thailand
  • 5.4.10 Malaysia
  • 5.4.11 Philippines
  • 5.4.12 Vietnam
• 5.5 Central & South America
  • 5.5.1 Central & South America Biologics Consumption by Application
  • 5.5.2 Central & South America Biologics Consumption by Countries
  • 5.5.3 Brazil
• 5.6 Middle East and Africa
  • 5.6.1 Middle East and Africa Biologics Consumption by Application
  • 5.6.2 Middle East and Africa Biologics Consumption by Countries
  • 5.6.3 Turkey
  • 5.6.4 GCC Countries
  • 5.6.5 Egypt
  • 5.6.6 South Africa

6 Market Size by Type

• 6.1 Global Biologics Breakdown Dada by Type
• 6.2 Global Biologics Revenue by Type
• 6.3 Biologics Price by Type

7 Market Size by Application

• 7.1 Overview
• 7.2 Global Biologics Breakdown Dada by Application
  • 7.2.1 Global Biologics Consumption by Application
  • 7.2.2 Global Biologics Consumption Market Share by Application (2014-2019)

8 Manufacturers Profiles

• 8.1 Eli Lilly & Company
  • 8.1.1 Eli Lilly & Company Company Details
  • 8.1.2 Company Description
  • 8.1.3 Capacity, Production and Value of Biologics
  • 8.1.4 Biologics Product Description
  • 8.1.5 SWOT Analysis
• 8.2 Samsung Biologics
  • 8.2.1 Samsung Biologics Company Details
  • 8.2.2 Company Description
  • 8.2.3 Capacity, Production and Value of Biologics
  • 8.2.4 Biologics Product Description
  • 8.2.5 SWOT Analysis
• 8.3 F Hoffman La Roche
  • 8.3.1 F Hoffman La Roche Company Details
  • 8.3.2 Company Description
  • 8.3.3 Capacity, Production and Value of Biologics
  • 8.3.4 Biologics Product Description
  • 8.3.5 SWOT Analysis
• 8.4 Celltrion
  • 8.4.1 Celltrion Company Details
  • 8.4.2 Company Description
  • 8.4.3 Capacity, Production and Value of Biologics
  • 8.4.4 Biologics Product Description
  • 8.4.5 SWOT Analysis
• 8.5 Addgene
  • 8.5.1 Addgene Company Details
  • 8.5.2 Company Description
  • 8.5.3 Capacity, Production and Value of Biologics
  • 8.5.4 Biologics Product Description
  • 8.5.5 SWOT Analysis
• 8.6 Amgen
  • 8.6.1 Amgen Company Details
  • 8.6.2 Company Description
  • 8.6.3 Capacity, Production and Value of Biologics
  • 8.6.4 Biologics Product Description
  • 8.6.5 SWOT Analysis
• 8.7 Abbvie Inc.
  • 8.7.1 Abbvie Inc. Company Details
  • 8.7.2 Company Description
  • 8.7.3 Capacity, Production and Value of Biologics
  • 8.7.4 Biologics Product Description
  • 8.7.5 SWOT Analysis
• 8.8 Sanofi
  • 8.8.1 Sanofi Company Details
  • 8.8.2 Company Description
  • 8.8.3 Capacity, Production and Value of Biologics
  • 8.8.4 Biologics Product Description
  • 8.8.5 SWOT Analysis
• 8.9 Pfizer Inc.
  • 8.9.1 Pfizer Inc. Company Details
  • 8.9.2 Company Description
  • 8.9.3 Capacity, Production and Value of Biologics
  • 8.9.4 Biologics Product Description
  • 8.9.5 SWOT Analysis
• 8.10 Merck & Co. Inc.
  • 8.10.1 Merck & Co. Inc. Company Details
  • 8.10.2 Company Description
  • 8.10.3 Capacity, Production and Value of Biologics
  • 8.10.4 Biologics Product Description
  • 8.10.5 SWOT Analysis
• 8.11 Novo Nordisk A/S
• 8.12 Johnson & Johnson Services Inc.

9 Production Forecasts

• 9.1 Biologics Production and Revenue Forecast
  • 9.1.1 Global Biologics Production Forecast 2019-2025
  • 9.1.2 Global Biologics Revenue Forecast 2019-2025
• 9.2 Biologics Production and Revenue Forecast by Regions
  • 9.2.1 Global Biologics Revenue Forecast by Regions
  • 9.2.2 Global Biologics Production Forecast by Regions
• 9.3 Biologics Key Producers Forecast
  • 9.3.1 United States
  • 9.3.2 Europe
  • 9.3.3 China
  • 9.3.4 Japan
• 9.4 Forecast by Type
  • 9.4.1 Global Biologics Production Forecast by Type
  • 9.4.2 Global Biologics Revenue Forecast by Type

10 Consumption Forecast

• 10.1 Consumption Forecast by Application
• 10.2 Biologics Consumption Forecast by Regions
• 10.3 North America Market Consumption Forecast
  • 10.3.1 North America Biologics Consumption Forecast by Countries 2019-2025
  • 10.3.2 United States
  • 10.3.3 Canada
  • 10.3.4 Mexico
• 10.4 Europe Market Consumption Forecast
  • 10.4.1 Europe Biologics Consumption Forecast by Countries 2019-2025
  • 10.4.2 Germany
  • 10.4.3 France
  • 10.4.4 UK
  • 10.4.5 Italy
  • 10.4.6 Russia
• 10.5 Asia Pacific Market Consumption Forecast
  • 10.5.1 Asia Pacific Biologics Consumption Forecast by Countries 2019-2025
  • 10.5.2 China
  • 10.5.3 Japan
  • 10.5.4 Korea
  • 10.5.5 India
  • 10.5.6 Australia
  • 10.5.7 Indonesia
  • 10.5.8 Thailand
  • 10.5.9 Malaysia
  • 10.5.10 Philippines
  • 10.5.11 Vietnam
• 10.6 Central & South America Market Consumption Forecast
  • 10.6.1 Central & South America Biologics Consumption Forecast by Country 2019-2025
  • 10.6.2 Brazil
• 10.7 Middle East and Africa Market Consumption Forecast
  • 10.7.1 Middle East and Africa Biologics Consumption Forecast by Countries 2019-2025
  • 10.7.2 Middle East and Africa
  • 10.7.3 Turkey
  • 10.7.4 GCC Countries
  • 10.7.5 Egypt
  • 10.7.6 South Africa

11 Upstream, Industry Chain and Downstream Customers Analysis

• 11.1 Analysis of Biologics Upstream Market
  • 11.1.1 Biologics Key Raw Material
  • 11.1.2 Typical Suppliers of Key Biologics Raw Material
  • 11.1.3 Biologics Raw Material Market Concentration Rate
• 11.2 Biologics Industry Chain Analysis
• 11.3 Marketing & Distribution
• 11.4 Biologics Distributors
• 11.5 Biologics Customers

12 Opportunities & Challenges, Threat and Affecting Factors

• 12.1 Market Opportunities
• 12.2 Market Challenges
• 12.3 Porter's Five Forces Analysis

13 Key Findings

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
  • 14.1.2 Data Source
• 14.2 Author Details

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA.
North America dominated with respect to revenue generation owing to the presence of significant established participants in this region. Moreover, higher demand for the products for treatment of diseases is attributive for larger revenue share.
Global Biologics market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Biologics.

This report researches the worldwide Biologics market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Biologics breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

The following manufacturers are covered in this report:
Eli Lilly & Company
Samsung Biologics
F Hoffman La Roche
Celltrion
Addgene
Amgen
Abbvie Inc.
Sanofi
Pfizer Inc.
Merck & Co. Inc.
Novo Nordisk A/S
Johnson & Johnson Services Inc.

Biologics Breakdown Data by Type
Monoclonal Antibodies
Vaccines
Recombinant Proteins
Antisense
RNAi
Biologics Breakdown Data by Application
Infectious Diseases
Oncology
Immunology
Autoimmune Diseases

Biologics Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions

Biologics Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa

The study objectives are:
To analyze and research the global Biologics capacity, production, value, consumption, status and forecast;
To focus on the key Biologics manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Biologics :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.